Responsibility

Thriving with Our Shared Community & Environment in Mind

At Kent-Athlone Pharma Group, we are guided by our vision to set a standard in excellence with quality products and services to our partners. We realise this vision by putting compliance first, every time. Our EcoVadis Gold medal accreditation is a testament to the integration of international sustainability standards and corporate social responsibility into the business and management system across four aspects: environment, labour and human rights, ethics and sustainable procurement.

Our corporate social responsibility strategy
focuses on two priorities

Protecting Our Environment

The Company is committed to reducing its greenhouse gas (GHG) emissions and to protecting the environment in which we operate. We believe it is our responsibility to safeguard the environment and strive for continuous improvement to minimise the impact of our operations. To further our progress towards achieving Net Zero by 2050, Kent-Athlone Pharma Group has adopted the target of lowering scope 1 and 2 emissions by 20% and scope 3 emissions by 10% by 2029. This initiative aims to reduce total emissions to 27,484 CO₂e.

Carbon Reduction Plan

We are committed to achieving Net Zero emissions by 2050

Completed Carbon Reduction Initiatives

Supply chain transition for efficient management and waste reduction

Implementation of Blue Yonder warehouse management system in the UK 3PL

Sustainable business travel options

Including participation in a carbon off-setting programme and a fleet of electric and hybrid company cars

Waste management

Established partnerships with suppliers offering  carbon off-setting services

Future Carbon Reduction Initiatives

Become signatories of the
United Nations Global Compact

Align business operations with the UNDP
Sustainable Development Goals

Transition to renewable energy sources

To increase our use of renewable
energy sources by 50% by 2030

Assess GHG Scope 3 emissions

Through the engagement of
a third-party entity

Our Commitment to Preventing Modern Slavery

As part of the pharmaceutical sector, we recognise the importance of taking a strong stance against slavery and human trafficking. The Company is committed to preventing slavery and human trafficking in all forms, both within our operations and throughout our supply chains. This commitment is evident in our adherence to the principles of the UN Global Compact, our alignment with the UNDP Sustainable Development Goals, and our EcoVadis accreditation in 2025.

Modern Slavery & Human Trafficking Statement

Kent-Athlone Pharma Group is committed to acting in the best interests of the global community in which it operates, ensuring that all applicable legislation, regulations, Codes of Conduct, and industry best practice are adhered to.

Terry Petersen, CEO

If you require general information concerning one of our products, including availability, please contact our customer services team: